Journal of Bioethical Inquiry

, Volume 14, Issue 1, pp 87–96 | Cite as

How Should We Respond to Non-Dominant Healing Practices, the Example of Homeopathy

Original Research

Abstract

The debate around the ethics of homeopathy in recent issues of the journal has been approached as a binary question; is homeopathy ethical or not? This paper suggests that this is an unhelpful question and instead discusses a framework to establish the extent to which the dominant (medical) culture should tolerate non-dominant health practices such as homeopathy. This requires a sophisticated understanding of the placebo effect, a critical evaluation of what evidence is available, a consideration of the harm that the non-dominant practice might cause, and a consideration of how this might be affected by the culture of the patient. This is presented as a matter of cultural competence. At a clinical level clinicians need to respect the values and beliefs of their patients and communicate with all the practitioners involved in a patient’s care. At a societal level there are a number of factors to be considered when a community decides which practices to tolerate and to what extent.

Keywords

Homeopathy Ethics of placebo Cultural diversity Complementary and alternative medicine 

References

  1. Accident Compensation Corporation. 2016. What support can I get. http://www.acc.co.nz/making-a-claim/what-support-can-i-get/WCM001816. Accessed November 22, 2016.
  2. Auckland University of Technology. 2016. Maori Dictionary OnLine. http://maoridictionary.co.nz/search?idiom=&phrase=&proverb=&loan=&histLoanWords=&keywords=tohunga. Accessed November 22, 2016.
  3. Beasley, R., T. Clayton, J. Crane, et al. 2008. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: Analysis from Phase Three of the ISAAC programme. The Lancet 372(9643): 1039–1048.CrossRefGoogle Scholar
  4. Boon, H., H. MacPherson, S. Fleishman, et al. 2007. Evaluating complex healthcare systems: A critique of four approaches. Evidence-Based Complementary and Alternative Medicine 4(3): 279–285.CrossRefPubMedGoogle Scholar
  5. British Homeopathic Association. 2016. Homeopathy and the NHS. http://www.britishhomeopathic.org/what-is-homeopathy/homeopathy-and-the-nhs/. Accessed November 22, 2016.
  6. Daly, F.F., J.S. Fountain, L. Murray, A. Graudins, and N.A. Buckley. 2008. Guidelines for the management of paracetamol poisoning in Australia and New Zealand—Explanation and elaboration. Medical Journal of Australia 188(5): 296–301.PubMedGoogle Scholar
  7. Doshi, P., T. Jefferson, and C. Del Mar. 2012. The imperative to share clinical study reports: Recommendations from the Tamiflu experience. PLoS Medicine 9(4): e1001201.Google Scholar
  8. Ehrlich, S. 2015. Homeopathy. University of Maryland Medical Center.http://umm.edu/health/medical/altmed/treatment/homeopathy. Accessed November 22, 2016.
  9. Essén, B., and S. Johnsdotter. 2004. Female genital mutilation in the West: Traditional circumcision versus genital cosmetic surgery. Acta Obstetricia et Gynecologica Scandinavica 83(7): 611–613.CrossRefPubMedGoogle Scholar
  10. Fadiman, A. 1997. The spirit catches you and you fall down: A Hmong child, her American doctors, and the collision of two cultures. New York: Farrar, Straus, and Giroux.Google Scholar
  11. Fink, P., M. Rosendal, and F. Olesen. 2005. Classification of somatization and functional somatic symptoms in primary care. Australian and New Zealand Journal of Psychiatry 39(9): 772–781.CrossRefPubMedGoogle Scholar
  12. Finniss, D.G., T.J. Kaptchuk, F. Miller, and F. Benedetti. 2010. Biological, clinical, and ethical advances of placebo effects. The Lancet 375(9715): 686–695.CrossRefGoogle Scholar
  13. Fitzpatrick, S.J. 2015. Scientism as a social response to the problem of suicide. Journal of Bioethical Inquiry 12(4): 613–622.CrossRefPubMedGoogle Scholar
  14. Frank, J.D. 1971. Therapeutic factors in psychotherapy. American Journal of Psychotherapy.Google Scholar
  15. Godlee, F., J. Smith, and H. Marcovitch. 2011. Wakefield’s article linking MMR vaccine and autism was fraudulent. BMJ 342: c7452.CrossRefPubMedGoogle Scholar
  16. Goldacre, B. 2012. Bad pharma : How drug companies mislead doctors and harm patients. London: Fourth Estate.Google Scholar
  17. Grant, K. 2014. Ontario hospital cannot force chemo on 11-year-old native girl, court rules. The Globe and Mail, November 14. http://www.theglobeandmail.com/life/health-and-fitness/health/cancer-patient-has-right-to-use-aboriginal-healing-instead-of-chemo-judge-rules/article21587859/. Accessed November 22, 2016.
  18. Gray, B. 2016. Clinical ethics cultural competence and the importance of dialogue: A case study. Clinical Research and Bioethics 7(1): 1000256.Google Scholar
  19. Greenhalgh, T., J. Howick, and N. Maskrey. 2014. Evidence based medicine: A movement in crisis? British Medical Journal 348: g3725.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Hall, H. 2013. Faith healing: Religious freedom vs. child protection. Skeptical Inquirer 38(4). http://www.csicop.org/si/show/faith_healing_religious_freedom_vs._child_protection. Accessed November 22, 2016.
  21. Hanna, M., and M. Honeychurch. 2015. Chronic misleading online advertising by chiropractors. The New Zealand Medical Journal 129(1432): 91–93.Google Scholar
  22. International Organization for Migration (IOM). 2015. World Migration Report. Geneva Switzerland. http://publications.iom.int/system/files/wmr2015_en.pdf. Accessed November 22, 2016.
  23. Kaiser, L., C. Wat, T. Mills, P. Mahoney, P. Ward, and F. Hayden. 2003. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Archives of Internal Medicine 163(14): 1667–1672.CrossRefPubMedGoogle Scholar
  24. Krosch, S.L. 2010. Perceptions and use of complementary and alternative medicine in American Samoa: A survey of health care providers. Hawaii Medical Journal 69(6): 21–26.PubMedPubMedCentralGoogle Scholar
  25. Lambert, M.J. 2005. Early response in psychotherapy: Further evidence for the importance of common factors rather than “placebo effects.” Journal of Clinical Psychology 61(7): 855–869.CrossRefPubMedGoogle Scholar
  26. Laska, K.M., A.S. Gurman, and B.E. Wampold. 2014. Expanding the lens of evidence-based practice in psychotherapy: A common factors perspective. Psychotherapy 51(4): 467.CrossRefPubMedGoogle Scholar
  27. Levy, D., B. Gadd, I. Kerridge, and P. Komesaroff. 2014. A gentle ethical defence of homeopathy. Journal of Bioethical Inquiry 12(2): 1–7.Google Scholar
  28. Medical Council of New Zealand. 2006. Statement on cultural competence. http://www.mcnz.org.nz/assets/News-and-Publications/Statements/Statement-on-cultural-competence.pdf. Accessed November 22, 2016.
  29. Medical Council of New Zealand. 2011. Statement on complementary and alternative medicine. https://www.mcnz.org.nz/assets/News-and-Publications/Statements/Complementary-and-alternative-medicine.pdf. Accessed November 22, 2016.
  30. Ministry of Health New Zealand. 2015. Responsible authorities under the Act. http://www.health.govt.nz/our-work/regulation-health-and-disability-system/health-practitioners-competence-assurance-act/responsible-authorities-under-act. Accessed November 22 2016.
  31. Moynihan, R., J. Doust, and D. Henry. 2012. Preventing overdiagnosis: How to stop harming the healthy. British Medical Journal 344: e3502.CrossRefPubMedGoogle Scholar
  32. New Zealand Council of Homeopaths. 2010. NZCH rules of practice and code of ethics. http://www.homeopathy.co.nz/assets/pdf/public/nzch-rules-of-practice-and-code-of-ethics-august-2010.pdf. Accessed November 22, 2016.
  33. New Zealand Medical Association. 2014. Code of ethics for the New Zealand medical profession. https://www.nzma.org.nz/__data/assets/pdf_file/0016/31435/NZMA-Code-of-Ethics-2014-A4.pdf. Accessed November 22, 2016.
  34. Nimnuan, C., M. Hotopf, and S. Wessely. 2001. Medically unexplained symptoms: An epidemiological study in seven specialities. Journal of Psychosomatic Research 51(1): 361–367.CrossRefPubMedGoogle Scholar
  35. Parekh, B. 1996. Minority practices and principles of toleration. International Migration Review 30(1): 251–284.CrossRefGoogle Scholar
  36. Pearce, N., R. Beasley, J. Crane, C. Burgess, and R. Jackson. 1995. End of the New Zealand asthma mortality epidemic. The Lancet 345(8941): 41–44.CrossRefGoogle Scholar
  37. Pharmac. 2016. Rongoā Medicine. https://www.pharmac.govt.nz/maori/he-rongoa-pai/rongoa-medicine/. Accessed November 22, 2016.
  38. Pickering, N. 2015. When lack of evidence is evidence of lack. Journal of Bioethical Inquiry 12(4): 545–547.CrossRefPubMedGoogle Scholar
  39. Pledger, M.J., J. Cumming, and M. Burnette. 2010. Health service use amongst users of complementary and alternative medicine. The New Zealand Medical Journal (Online) 123(1312): 26–35.Google Scholar
  40. Pollo, A., M. Amanzio, A. Arslanian, C. Casadio, G. Maggi, and F. Benedetti. 2001. Response expectancies in placebo analgesia and their clinical relevance. Pain 93(1): 77–84.CrossRefPubMedGoogle Scholar
  41. Popovich, D., A. McAlhany, A.O. Adewumi, and M. McKim Barnes. 2009. Scurvy: Forgotten but definitely not gone. Journal of Pediatric Health Care 23(6): 405–415.CrossRefPubMedGoogle Scholar
  42. Ramsden, I. 1992. Teaching cultural safety. New Zealand Nursing Journal. Kai Tiaki 85(5): 21–23.PubMedGoogle Scholar
  43. Rauws, E., and G. Tytgat. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. The Lancet 335(8700): 1233–1235.CrossRefGoogle Scholar
  44. Richardson, E. 2016. Health policy brief: Transparency in clinical research. Health Affairs, January 14. http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=150. Accessed November 22, 2016.
  45. Sackett, D.L., W.M. Rosenberg, J. Gray, R.B. Hayes, and W.S. Richardson. 1996. Evidence based medicine: What it is and what it isn’t. BMJ: British Medical Journal 312(7023): 71–72.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Shaneyfelt, T.M., and R.M. Centor. 2009. Reassessment of clinical practice guidelines: Go gently into that good night. JAMA 301(8): 868–869.CrossRefPubMedGoogle Scholar
  47. Shaw, D. 2015. A strong remedy to a weak ethical defence of homeopathy. Journal of Bioethical Inquiry 12(4): 549–553.CrossRefPubMedGoogle Scholar
  48. Shaw, D., G. Lefebvre, C. Bouchard, et al. 2013. Female genital cosmetic surgery. Journal of Obstetrics and Gynaecology Canada 35(12): 1108–1112.CrossRefPubMedGoogle Scholar
  49. Sihvonen, R., M. Paavola, A. Malmivaara, et al. (2013) Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. New England Journal of Medicine 369(26): 2515–2524.CrossRefPubMedGoogle Scholar
  50. Taylor, J.S. 2003. Confronting “culture” in medicine’s “culture of no culture.” Academic Medicine 78(6): 555–559.CrossRefPubMedGoogle Scholar
  51. Thomas, K., and M. Schmidt. 2012. Glaxo agrees to pay $3 billion in fraud settlement. New York Times, July 2.Google Scholar
  52. Thomas, K.B. 1987. General practice consultations: Is there any point in being positive? British Medical Journal 294(6581): 1200–1202.CrossRefPubMedPubMedCentralGoogle Scholar
  53. Tricoci, P., J.M. Allen, J.M. Kramer JM, R.M. Califf, and S.C. Smith. 2009. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301(8): 831–841.Google Scholar
  54. Wakefield, A.J., S.H. Murch, A.L. Anthony, et al. 1998. Ileal lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children [retracted]. Lancet 351(9103): 637–641.CrossRefPubMedGoogle Scholar
  55. Washington, H.A. 2011. Deadly monopolies: The shocking corporate takeover of life itself, and the consequences for your health and our medical future. New York: Doubleday.Google Scholar

Copyright information

© Journal of Bioethical Inquiry Pty Ltd. 2016

Authors and Affiliations

  1. 1.Otago University WellingtonNewtownNew Zealand

Personalised recommendations